Chelated minerals

Trace minerals — zinc, iron, copper, manganese — are supplied to animals and people as supplements, and the form matters more than the amount. Chelated or “organic” minerals are metal ions coordinated to an organic ligand, usually an amino acid, a short peptide or an organic acid, and the reason they exist is that a free ion in the gut is in a hostile environment.

What goes wrong with a free ion

An inorganic salt dissociates in the stomach, releasing the metal as a free cation. As it passes into the more alkaline small intestine, several things compete for it. Phytate binds divalent cations strongly and forms insoluble complexes. Fibre, oxalate, tannins and phosphate do the same. Hydroxide itself precipitates iron at intestinal pH.

Minerals also compete with each other. Iron, zinc, copper and manganese share transport routes at the enterocyte — the divalent metal transporter DMT1 among them — so a large dose of one reduces uptake of another. High dietary zinc inducing copper deficiency is a well-established example of this, not a theoretical concern.

The net result is that only a modest fraction of an inorganic mineral dose reaches the bloodstream, and the fraction varies with the rest of the meal.

What the ligand does

A chelate is a complex in which the ligand binds the metal at two or more points, forming a ring. That multi-point attachment makes the complex far more stable than a single-point association.

Three consequences follow. The metal is kept in solution across the pH change from stomach to intestine. It is shielded from phytate and other precipitants, because its coordination sites are already occupied. And it is less available to compete for shared transporters, since it is no longer a free cation — some amino-acid chelates are thought to be absorbed at least partly through peptide or amino-acid transport routes rather than the metal ones.

The stability constant has to sit in a window

This is the point that decides whether a chelate is any good, and it is a genuine engineering constraint.

If the ligand binds too weakly, the complex dissociates in the stomach and the metal behaves exactly like an inorganic salt. Many products marketed as chelates are simple mixtures or weak complexes that do not survive gastric conditions.

If the ligand binds too strongly, the complex is stable enough to pass through unabsorbed, or is absorbed and excreted intact without releasing the metal to the tissues that need it. A very high stability constant is not a selling point.

Useful chelates therefore occupy an intermediate range, and the relevant specification is the stability constant together with evidence that the complex is actually intact at gastric pH — not merely the presence of an organic ligand in the name.

Reading the claims

Bioavailability advantages over inorganic salts are real but usually moderate, and they are largest exactly where the free ion has most to lose: high-phytate diets, high mineral antagonism, and animals under stress. In a low-phytate diet with adequate intake, the difference narrows. Comparative trials vary in outcome, partly because “chelate” covers products of very different actual chemistry, and results obtained with one should not be assumed for another.